Lupin US Subsidiary Settles Antitrust Litigation for $30M

Lupin discloses US subsidiary Lupin Pharmaceuticals Inc. settled antitrust litigation with Humana Inc. for $30 million.
The settlement provides full release of claims against LPI and related parties, with LPI denying all allegations.
The settlement amount was already provisioned in the company's prior consolidated financial results.
Disclosure made pursuant to SEBI Listing Regulations Regulation 30 regarding material legal proceedings.